Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a:

Erin L. MacMillan,Julia Schubert,Irene M. Vavasour,Roger Tam,Alexander Rauscher,Carolyn Taylor,Richard Allen White,Hideki Garren,David Clayton,Victoria Levesque,David Kb Li,Shannon H. Kolind,Anthony Traboulsee

Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a:

2019

Erin L. MacMillan
Julia Schubert
Irene M. Vavasour
Roger Tam
Alexander Rauscher
Carolyn Taylor
Richard Allen White
Hideki Garren
David Clayton
Victoria Levesque
David Kb Li
Shannon H. Kolind
Anthony Traboulsee

BackgroundMagnetic resonance spectroscopy quantitatively monitors biomarkers of neuron-myelin coupling (N-acetylaspartate (NAA)), and inflammation (total creatine (tCr), total choline (tCho), myo-i...

Keywords:

T-cell receptor
Creatine
Nuclear magnetic resonance spectroscopy
Multiple sclerosis
Gliosis
Interferon beta-1a
Nuclear magnetic resonance
Ocrelizumab
Choline
Chemistry
Inflammation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations